GSK: new placement of 3.2% of Haleon's capital -January 17, 2024 at 04:45 am EST
GSK announced on Wednesday that it had sold almost 3.2% of the share capital of its former consumer healthcare subsidiary Haleon in an accelerated placement worth around 978 million pounds .The...